SCHEMBL26469817

SCHEMBL26469817

COC(=O)c1ccccc1-c1cc2c(cc1OC)C(C)(C)c1ccccc1-2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 Q01959 5/20 0.43
▸ SLC6A4 P31645 3/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ PDK2 Q15119 6/20 0.41
▸ MAPK1 P28482 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 3/20 0.40
▸ TSHR P16473 3/20 0.40
▸ HTT P42858 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ CHEK1 O14757 1/20 0.40
▸ ROCK2 O75116 1/20 0.39
▸ CSF1R P07333 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ FLT3 P36888 1/20 0.39
▸ GSK3A P49840 1/20 0.39
▸ GSK3B P49841 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29294796 0.79 SLC6A3 (0.61) SLC6A3SLC6A4SLC6A2PDK2HSD17B10
SCHEMBL29295035 0.78 SLC6A3 (0.64) SLC6A3SLC6A4SLC6A2PDK2HSD17B10
SCHEMBL29879506 0.77 ALDH1A1 (0.47) SLC6A3SLC6A4SLC6A2PDK2HSD17B10
SCHEMBL26631821 0.77 ALDH1A1 (0.47) SLC6A3SLC6A4SLC6A2PDK2HSD17B10
SCHEMBL26631826 0.77 ALDH1A1 (0.47) SLC6A3SLC6A4SLC6A2PDK2HSD17B10
SCHEMBL22256463 0.77 PDK2 (0.56) SLC6A3SLC6A4SLC6A2PDK2HSD17B10
SCHEMBL21190471 0.76 SLC6A3 (0.61) SLC6A3SLC6A4SLC6A2MAPK1HSD17B10
SCHEMBL26469821 0.75 PDK2 (0.37) PDK2KDM4EMAPTMEN1KMT2A
SCHEMBL10025081 0.75 PDK2 (0.50) PDK2KDM4ECHEK1SMN1; SMN2LMNA
SCHEMBL19421342 0.75 PDK2 (0.52) SLC6A3SLC6A4SLC6A2PDK2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137213-A1 NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2023-05-04 — — US disclosed
US-20230137213-A1 NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2023-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230137213-A1 NOVEL PHENANTHROLINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME PPOX, PAH, CRY2 SLC6A3 4181/4885SLC6A4 4182/4885SLC6A2 3594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback